- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01344928
The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes (HITPET)
April 28, 2011 updated by: Turku University Hospital
The objectives of this study are to investigate the effects of short-time high-intensity interval training on tissue glucose and fat metabolism in healthy lean subjects and type 2 diabetic patients using modern and noninvasive imaging methods positron emission tomography (PET), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Turku, Finland, 20521
- Recruiting
- Turku PET Centre
-
Contact:
- Jarna C Hannukainen, PhD
- Phone Number: +358-2-3131878
- Email: jarna.hannukainen@tyks.fi
-
Principal Investigator:
- Jarna C Hannukainen, PhD
-
Sub-Investigator:
- Kari K Kalliokoski, PhD
-
Sub-Investigator:
- Joonas J Eskelinen, BM
-
Sub-Investigator:
- Anna Savolainen, BM
-
Sub-Investigator:
- Ilkka Heinonen, PhD
-
Sub-Investigator:
- Kirsi A Virtanen, PhD
-
Sub-Investigator:
- Jukka Kemppainen, PhD
-
Sub-Investigator:
- Juhani Knuuti, Professor
-
Sub-Investigator:
- Pirjo Nuutila, Professor
-
Sub-Investigator:
- Jussi Pärkkä, MD
-
Sub-Investigator:
- Virva Lepomäki, MSc
-
Sub-Investigator:
- Riitta Parkkola, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
The healthy patients
- Age 40-55
- BMI 18.5-30
- Fasting plasma glucose less than 6.1 mmol/l
- Normal glucose tolerance test (OGTT)
The type 2 diabetic patients:
- Age-, sex-, and BMI-matched with the study subjects in the phase 1
- In a good treatment balance
- Glycated haemoglobin (HbA1c) less than 7.5 mmol/l
- Two hours glucose value in oral glucose tolerance test (OGTT) less than 10.0 mmol/l
Exclusion Criteria:
The healthy patients
- Blood pressure > 140/90 mmHg
- Any chronic disease
- Any chronic medical defect or injury which hinder/interfere everyday life
- History of anorexia nervosa or bulimia
- History of rest or exercise-induced asthma
- Previous use of anabolic steroids, additives or any other substrates
- Smoking of tobacco, taking of snuffs, or use of narcotics.
- Significant use of alcohol
- Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
- Presence of any ferromagnetic objects that would make MR imaging contraindicated
- Current or history of regular and systematic exercise training
- VO2max >40 ml/min/kg
The type 2 diabetic patients:
- Any other chronic disease than diabetes
- Blood pressure > 140/90 mmHg
- Any chronic medical defect or injury which hinder/interfere everyday life
- History of anorexia nervosa or bulimia
- History of rest or exercise-induced asthma
- Smoking of tobacco, taking of snuffs, or use of narcotics.
- Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
- Presence of any ferromagnetic objects that would make MRI imaging contraindicated
- Current or history of regular and systematic exercise training
- VO2max >40 ml/ min/kg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIT training
|
|
|
Active Comparator: Aerobic exercise training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ojala R, Motiani KK, Ivaska KK, Arponen M, Eskelinen JJ, Virtanen KA, Loyttyniemi E, Heiskanen MA, U-Din M, Nuutila P, Kalliokoski KK, Hannukainen JC. Bone Marrow Metabolism Is Impaired in Insulin Resistance and Improves After Exercise Training. J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4290-303. doi: 10.1210/clinem/dgaa516.
- Motiani KK, Collado MC, Eskelinen JJ, Virtanen KA, Loyttyniemi E, Salminen S, Nuutila P, Kalliokoski KK, Hannukainen JC. Exercise Training Modulates Gut Microbiota Profile and Improves Endotoxemia. Med Sci Sports Exerc. 2020 Jan;52(1):94-104. doi: 10.1249/MSS.0000000000002112.
- Heiskanen MA, Motiani KK, Mari A, Saunavaara V, Eskelinen JJ, Virtanen KA, Koivumaki M, Loyttyniemi E, Nuutila P, Kalliokoski KK, Hannukainen JC. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial. Diabetologia. 2018 Aug;61(8):1817-1828. doi: 10.1007/s00125-018-4627-x. Epub 2018 May 2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
April 28, 2011
First Submitted That Met QC Criteria
April 28, 2011
First Posted (Estimate)
April 29, 2011
Study Record Updates
Last Update Posted (Estimate)
April 29, 2011
Last Update Submitted That Met QC Criteria
April 28, 2011
Last Verified
April 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 95/180/2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
Canterbury Christ Church UniversityBarts & The London NHS Trust; Betsi Cadwaladr University Health BoardRecruitingType 1 Diabetes Mellitus | Type 2 Diabetes Mellitus (T2DM)United Kingdom
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
Clinical Trials on HIT exercise intervention
-
University of Erlangen-Nürnberg Medical SchoolCompletedMuscle Weakness | Exercise | Muscle Atrophy | DetrainingGermany
-
University of Erlangen-Nürnberg Medical SchoolKlinikum NürnbergCompleted
-
Jarle BergeNorwegian University of Science and Technology; Duke University; University of... and other collaboratorsActive, not recruiting
-
Dara SorkinCompletedDepression | Post-Traumatic Stress Disorder
-
Charles Drew University of Medicine and ScienceWithdrawnDepression | Obesity | Anxiety | Mental Health Wellness 1 | Sedentary Behavior | Poor Nutrition
-
Hasselt UniversityJessa HospitalUnknown
-
University GhentCompletedOverweight and Obesity
-
Chulalongkorn UniversityCompletedAllergic RhinitisThailand
-
University of Erlangen-Nürnberg Medical SchoolCompletedOsteopenia, OsteoporosisGermany
-
Lund UniversityLund University HospitalRecruitingNeoplasms | Radiotherapy Side Effect | Lymphedema of Face | Lymphedema Due to RadiationSweden